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The intranasal (IN) route shows promise for chemical restraint given the large area offered for 
drugs absorption. The nasal turbinates increase nasal mucosa surface, which have a greater 
blood flow than muscle, brain and liver tissue (Dale et al. 2002). Aim of the study is to compare 
the clinical effects and sedation scores following either IN or intramuscular (IM) administration 
of dexmedetomidine-methadone in dogs. Twenty mixed-breed, client-owned, healthy dogs, 
undergoing soft tissue surgery or diagnostic procedures, were randomly allocated in two groups 
(n = 10) to receive dexmedetomidine (0.01 mg kg-1) together with methadone (0.4 mg kg-1) IN 
(IN-group) or IM (IM-group). Temperament was evaluated before premedication (1 = calm and 
friendly, 4 = very excitable or nervous) (Maddern et al. 2010). Heart rate (HR), respiratory 
frequency (fR), body temperature, and side effects were recorded before (T0) and 10 (T10), 20 
(T20) and 30 (T30) minutes after premedication. Sedation was scored 3 times (every 10 minutes) 
after drugs administration using a descriptive sedation scale (0 = no sedation, 13 = extremely 
sedated) (Gurney et al. 2009). Induction was performed at T30 with titrate-to-effect propofol 
and the dosage was recorded. Student T-test was performed. Weight, age, temperament, body 
temperature and propofol dose were not different between groups (Table 1). At each time 
point, excluding T0, IM-group showed a statistically lower HR and fR compared to IN-group. No 
undesirable effects were observed in both groups. Sedation score in IM-group was significantly 
higher compared to IN-group at each time point. In conclusion, despite statistical differences, 
IN administration produces a satisfactory clinical sedation with more gradual hemodynamic 
effects compared to IM injection; this is probably due to a direct transport of drugs from cranial 
nerves (I-V) to brain with limited systemic absorption. However, the high variability recorded in 
sedation score between subjects in IN-group (min 1/13; max 13/13 at T30) probably arises from a 
variable drugs conveyance from nasal mucosae to target cell in CNS by IN administration. 
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Table 1: Value of weight, age, temperament, body temperature and propofol dose 
presented as a mean ± standard deviation and p-value in IN-group and IM-group. 
 IN-group IM-group p-value 
Weight (kg) 
 mean ± SD 
23 ± 7 26 ± 10 p=0.1 
Age (months)  
 mean ± SD 
21 ± 13 31 ± 16 p=0.07 
Temperament (1-4)  
mean ± SD 
2.6 ± 0.8 2.4 ± 0.9 p=0.3 
Body temperature (°C) mean ± SD 39,1 ± 0.1 39 ± 0.1 p=0.1 
Propofol dose (mg kg-1)  
mean ± SD 
2.4 ± 1 1.7 ± 0.9 p=0.06 
